Ganglioside GM2

Ganglioside GM2 is a lipid of Sphingolipids (SP) class. Ganglioside gm2 is associated with abnormalities such as Sensory neuropathy, Neuropathy, Autoimmune Diseases, Polyradiculoneuropathy, Chronic Inflammatory Demyelinating and Neuromuscular Diseases. The involved functions are known as Pressure- physical agent, Cytolysis, Inflammation, Complement-Dependent Cytotoxicity and conjugation. Ganglioside gm2 often locates in Membrane, Entire nervous system, Cell surface, Biopsy sample and Lipid Bilayers. The associated genes with Ganglioside GM2 are anti-IgM, Polypeptides, Transgenes, Alleles and Homologous Gene. The related lipids are Ganglioside GA2, QS 21, sulfate-3-glucuronyl paragloboside, Lipopolysaccharides and IV(4)-galactosyl-N-acetylganglioside GD1a. The related experimental models are Disease model.

Cross Reference

Introduction

To understand associated biological information of Ganglioside GM2, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with Ganglioside GM2?

Ganglioside GM2 is suspected in Tay-Sachs Disease, Gangliosidoses GM2, Sandhoff Disease, Neuropathy, Cytomegalovirus Infections, Niemann-Pick Diseases and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

No disease MeSH terms mapped to the current reference collection.

PubChem Associated disorders and diseases

What pathways are associated with Ganglioside GM2

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with Ganglioside GM2?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with Ganglioside GM2?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with Ganglioside GM2?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with Ganglioside GM2?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with Ganglioside GM2?

Disease model

Disease model are used in the study 'Development of GlcNAc-inspired iminocyclitiols as potent and selective N-acetyl-beta-hexosaminidase inhibitors.' (Ho CW et al., 2010) and Disease model are used in the study 'Therapeutic evaluation of GM2 gangliosidoses by ELISA using anti-GM2 ganglioside antibodies.' (Tsuji D et al., 2007).

Related references are published most in these journals:

Model Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

NCBI Entrez Crosslinks

All references with Ganglioside GM2

Download all related citations
Per page 10 20 50 100 | Total 558
Authors Title Published Journal PubMed Link
Gu J et al. Simultaneous quantification of GM1 and GM2 gangliosides by isotope dilution tandem mass spectrometry. 2008 Clin. Biochem. pmid:18241673
Baek RC et al. N-butyldeoxygalactonojirimycin reduces brain ganglioside and GM2 content in neonatal Sandhoff disease mice. 2008 Neurochem. Int. pmid:18207611
Li YT et al. Effect of structural modifications of ganglioside GM2 on intra-molecular carbohydrate-to-carbohydrate interaction and enzymatic susceptibility. 2008 Biochim. Biophys. Acta pmid:17967427
Nobile-Orazio E et al. How useful are anti-neural IgM antibodies in the diagnosis of chronic immune-mediated neuropathies? 2008 J. Neurol. Sci. pmid:17915254
Aguilar RP et al. Renal gangliosides are involved in lead intoxication. 2008 J Appl Toxicol pmid:17503479
Larsson EA et al. Synthesis of reference standards to enable single cell metabolomic studies of tetramethylrhodamine-labeled ganglioside GM1. 2007 Carbohydr. Res. pmid:17069778
Gavella M et al. Antioxidant properties of ganglioside micelles. 2007 Free Radic. Res. pmid:17886036
Alvarez-Rueda N et al. Binding activities and antitumor properties of a new mouse/human chimeric antibody specific for GD2 ganglioside antigen. 2007 Clin. Cancer Res. pmid:17875797
Raval G et al. TNF-alpha induction of GM2 expression on renal cell carcinomas promotes T cell dysfunction. 2007 J. Immunol. pmid:17475896
López-Requena A et al. Gangliosides, Ab1 and Ab2 antibodies III. The idiotype of anti-ganglioside mAb P3 is immunogenic in a T cell-dependent manner. 2007 Mol. Immunol. pmid:17316805
Martinez Z et al. GM1 specifically interacts with alpha-synuclein and inhibits fibrillation. 2007 Biochemistry pmid:17253773
Todeschini AR et al. Ganglioside GM2-tetraspanin CD82 complex inhibits met and its cross-talk with integrins, providing a basis for control of cell motility through glycosynapse. 2007 J. Biol. Chem. pmid:17215249
Kawashima I et al. Cytochemical analysis of storage materials in cultured skin fibroblasts from patients with I-cell disease. 2007 Clin. Chim. Acta pmid:17204262
Hasegawa D et al. Clinical and molecular analysis of GM2 gangliosidosis in two apparent littermate kittens of the Japanese domestic cat. 2007 J. Feline Med. Surg. pmid:17198760
Tsuji D et al. Therapeutic evaluation of GM2 gangliosidoses by ELISA using anti-GM2 ganglioside antibodies. 2007 Clin. Chim. Acta pmid:17196574
Zhao Y et al. Endowing self-binding feature restores the activities of a loss-of-function chimerized anti-GM2 antibody. 2007 Cancer Immunol. Immunother. pmid:16896968
López-Requena A et al. Gangliosides, Ab1 and Ab2 antibodies II. Light versus heavy chain: An idiotype-anti-idiotype case study. 2007 Mol. Immunol. pmid:16620986
Fuse T et al. Synthesis and enzymatic susceptibility of a series of novel GM2 analogs. 2006 Glycoconj. J. pmid:16897176
Itakura T et al. Inefficiency in GM2 ganglioside elimination by human lysosomal beta-hexosaminidase beta-subunit gene transfer to fibroblastic cell line derived from Sandhoff disease model mice. 2006 Biol. Pharm. Bull. pmid:16880605
Crawley AC et al. Characterization of a C57BL/6 congenic mouse strain of mucopolysaccharidosis type IIIA. 2006 Brain Res. pmid:16828069